default author photo

Lei Huo

University of Texas at Houston - MD Anderson Cancer Center

Unit 1905

Houston, TX

United States

SCHOLARLY PAPERS

2

DOWNLOADS

208

TOTAL CITATIONS

2

Scholarly Papers (2)

1.

TRPS1, GATA3, and SOX10 Expression in Triple-Negative Breast Carcinoma

Number of pages: 16 Posted: 18 Mar 2022
University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, Ohio State University (OSU), University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Dallas - Southwestern Medical Center, University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, affiliation not provided to SSRN, affiliation not provided to SSRN, Ohio State University (OSU), Ohio State University (OSU) - Wexner Medical Center, Ohio State University (OSU) - Wexner Medical Center, University of Texas at Houston - Division of Pathology and Laboratory Medicine, Ohio State University (OSU) and University of Texas at Houston - MD Anderson Cancer Center
Downloads 193 (395,523)
Citation 2

Abstract:

Loading...

TRPS1, GATA3, SOX10, triple-negative breast carcinoma

2.

Phase 2 Neoadjuvant Study of Enzalutamide and Paclitaxel in the Treatment of LAR-Enriched TNBC: Trial Results and Insight Into ARness

Number of pages: 103 Posted: 28 Jun 2023
University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Genomic Medicine, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - MD Anderson Cancer Center, Cold Spring Harbor Laboratory, University of Texas at Houston - Breast Medical Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, Baylor College of Medicine, Baylor College of Medicine, Baylor College of Medicine, University of Texas at Houston - Biostatistics, University of Texas at Houston - Department of Breast Medical Oncology, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - Department of Genomic Medicine, University of Texas at Houston - MD Anderson Cancer Center, University of Texas at Houston - MD Anderson Cancer Center, Baylor College of Medicine - Department of Surgery, University of Texas at Houston - Department of Breast Medical Oncology and University of Texas at Houston - Department of Breast Medical Oncology
Downloads 15 (1,500,778)

Abstract:

Loading...

Triple Negative Breast Cancer, Androgen receptor, Enzalutamide, ARness, Biomarker of response